Skip to main content

Take back your seat at the table

Gastroparesis can take away more than comfort or control over your day, it can take away your appetite for life.

Answer a few questions to see if Enterra® Therapy may help relieve your chronic nausea and vomiting symptoms.

You’re not alone.

Over 15,000 people have received Enterra Therapy to help relieve the nausea and vomiting symptoms of gastroparesis*.

Unlike other advanced treatment options, Enterra Therapy is the first and only device designed to relieve the nausea and vomiting symptoms of gastroparesis. It’s a small, implantable device that gently stimulates your stomach.

Learn more about gastroparesis and Enterra Therapy

(3:48)

Could Enterra Therapy be right for you?

Answer a few short questions to see if you may be a candidate and get a downloadable guide to help you start a conversation with your doctor.

Understand the technology behind Enterra Therapy

Learn more about gastric electrical stimulation (GES).

Find a provider

Search for Enterra Therapy providers.

Have questions about Enterra Therapy?

Our Enterra Patient Liaisons are trained professionals with healthcare experience.
They are here to help answer your questions.

Call 1-855-768-3772

Monday through Friday
8am to 5pm Eastern Time.

The information provided on this website is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always talk to your doctor about the best treatment options for your individual situation.

MKT-D-0003, Rev O

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

*HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?